DoD Awards $450M Contract for Coronavirus Antibody Manufacturing

Advanced Technology International (ATI) is a nonprofit who builds and manages collaborations that conduct research and develop new technologies to solve the nation’s most pressing challenges. ATI is the consortium manager for two JPEO-CBRND consortia.

Advanced Technology International, Summerville, South Carolina, was awarded a $450,392,000 modification (P00074) to contract W15QKN-16-9-1002 for large-scale manufacturing of antibodies directed to novel coronavirus.

Work will be performed in Summerville, South Carolina; and Tarrytown, New York, with an estimated completion date of June 30, 2021. Fiscal 2020 research, development, test, and evaluation, Army, funds in the amount of $450,392,000 were obligated at the time of the award.

U.S. Army Contracting Command, Newark, New Jersey, is the contracting activity.


The Role Nuclear-Related Techniques Play in Fighting Zoonotic Diseases

Moderna’s COVID-19 Vaccine Generally Well Tolerated in Ongoing Phase 1 Trial